CDKN2B-AS1 and osteosarcoma: Knockdown of ANRIL in the osteosarcoma cell lines was able to increase the Cisplatin-induced chemosensitivity via the upregulation of miR-125a-5p and reduction of its target gene STAT3 (Li et al., 2019).